VIOLIN Logo
VO Banner
Search: for Help
Vaxvec Home
Introduction
Statistics
News and Updates
Vaxvec Vectors
Vaxvec Vaccines
Vaxvec Antigens
VaxvecAg BLAST
Selected Vectors
B. abortus RB51 vector
RSV vaccine vector
SL3261 vaccine vector
VSV vaccine vector
Data Submission
Data Exchange
Data Download
Documentation
FAQs
Disclaimer
Contact Us
UMMS Logo

myxoma virus vaccine vector

Vaxvec ID 55
Vaccine Vector Name myxoma virus vaccine vector
Vector VO ID VO_0001062
Related Vaccine(s)
References
Bárcena et al., 2000: Bárcena J, Morales M, Vázquez B, Boga JA, Parra F, Lucientes J, Pagès-Manté A, Sánchez-Vizcaíno JM, Blasco R, Torres JM. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. Journal of virology. 2000; 74(3); 1114-1123. [PubMed: 10627521].
Gu et al., 2003: Gu W, Holland M, Janssens P, Kerr P. Antibody response in the female rabbit reproductive tract to influenza haemagglutinin encoded by a recombinant myxoma virus. Virology. 2003; 313(1); 286-295. [PubMed: 12951040].
Gu et al., 2004: Gu W, Holland M, Janssens P, Seamark R, Kerr P. Immune response in rabbit ovaries following infection of a recombinant myxoma virus expressing rabbit zona pellucida protein B. Virology. 2004; 318(2); 516-523. [PubMed: 14972520].
Kerr and Jackson, 1995: Kerr PJ, Jackson RJ. Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus. Vaccine. 1995; 13(17); 1722-1726. [PubMed: 8719525].
McCabe et al., 2002: McCabe VJ, Tarpey I, Spibey N. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine. 2002; 20(19-20); 2454-2462. [PubMed: 12057600].
Pignolet et al., 2008: Pignolet B, Boullier S, Gelfi J, Bozzetti M, Russo P, Foulon E, Meyer G, Delverdier M, Foucras G, Bertagnoli S. Safety and immunogenicity of myxoma virus as a new viral vector for small ruminants. The Journal of general virology. 2008; 89(Pt 6); 1371-1379. [PubMed: 18474552].
Top et al., 2011: Top S, Foulon E, Pignolet B, Deplanche M, Caubet C, Tasca C, Bertagnoli S, Meyer G, Foucras G. Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector. Journal of virology. 2011; 85(24); 12982-12994. [PubMed: 21835800].
Top et al., 2012: Top S, Foucras G, Deplanche M, Rives G, Calvalido J, Comtet L, Bertagnoli S, Meyer G. Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus. Vaccine. 2012; 30(9); 1609-1616. [PubMed: 22244980].